Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: consensus group recommendations from the German‐speaking countries

Abstract: Hepatorenal tyrosinaemia (HT1) is an autosomal recessive disorder of tyrosine degradation resulting in hepatic and renal dysfunction, neurological sequelae may occur in some patients. The use of nitisinone (NTBC) has revolutionised treatment and outcome of this disorder. NTBC has to be combined with a low protein diet. While NTBC modulates the disease course in HT1 patients, several issues are open. Optimal dosage, doses per day, therapeutic range of NTBC concentration, mode of protein restriction and biomarkers are not well defined. HCC and neurocognitive deficits are long-term sequelae. Early diagnosis and treatment are essential to minimise the risk for these complications. Clinical guidance for management of HT1-patients is required. Randomised clinical studies are difficult in the presence of therapeutic options. We discussed these issues in a consensus group of 10 paediatricians, 1 adult hepatologist, 1 geneticist, 2 dieticians, 2 newborn screening specialists with experience in HT1, 1 psychologist and 2 representatives of a patient group from the German-speaking countries (DACH). Recommendations were based on scientific literature and expert opinion, also taking into account recent experience with newborn screening. There was strong consensus that newborn screening using succinylacetone (SA) and early treatment are essential for a good outcome. The dose of NTBC should be as low as possible without losing metabolic control. This has to be accompanied by a low protein diet, in some patients a simplified diet without calculation of protein intake. Specific education and psychosocial support are recommended. Indications for liver transplantation were defined. Monitoring shall include clinical findings, levels of SA, tyrosine, phenylalanine and NTBC in (dried) blood

Objekt anzeigen

• Standort: Deutsche Nationalbibliothek Frankfurt am Main
• Umfang: Online-Ressource
• Sprache: Englisch
• Anmerkungen: Journal of inherited metabolic disease. - 48, 1 (2025) , e12824, ISSN: 1573-2665

Beteiligte, Orts- und Zeitangaben

• Ereignis: Veröffentlichung
• (wo): Freiburg
• (wer): Universität
• (wann): 2024
• Urheber: Das, Anibh Martin ; Ballhausen, Diana ; Haas, Dorothea ; Häberle, Johannes ; Hagedorn, Tobias ; Janson‐Mutsaerts, Cecilia ; Janzen, Nils ; Sander, Johannes ; Freisinger, Peter ; Karall, Daniela ; Meyer, Uta ; Mönch, Eberhard ; Morlot, Susanne ; Rosenbaum-Fabian, Stefanie ; Scholl-Bürgi, Sabine ; Vom Dahl, Stephan ; Weinhold, Natalie ; Zeman, Jiri ; Lange, Karin

Weitere Informationen

• DOI: 10.1002/jimd.12824
• URN: urn:nbn:de:bsz:25-freidok-2611667
• Rechteinformation: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.